Bulletin
Investor Alert

New York Markets Close in:

Market Pulse Archives

Jan. 25, 2021, 12:38 p.m. EST

J&J may share findings from Phase 3 vaccine trial this week

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Johnson & Johnson (JNJ)
  • X
    BioNTech SE ADR (BNTX)
  • X
    Pfizer Inc. (PFE)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +1.04% were up 0.9% in trading on Monday, as the company nears the anticipated disclosure of interim results from a late-stage clinical trial evaluating its single-dose COVID-19 vaccine candidate. J&J said in mid-December it expects to share findings from the Phase 3 trial by the end of January, which would it the third company testing coronavirus vaccines in the U.S. to announce results from a closely watched Phase 3 trial. The other two vaccines, developed by BioNTech SE /zigman2/quotes/214419716/composite BNTX +6.45% /Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.21% and Moderna Inc. /zigman2/quotes/205619834/composite MRNA -4.03% , are both mRNA-based vaccines that received emergency use authorization from the Food and Drug Administration in December. J&J said in December that it will file for emergency authorization for its experimental adenovirus-based vaccine in February if results are ready by the end of January. The company is expected to release its fourth-quarter and full-year earnings on Tuesday. J&J's stock has gained 10.9% over the past year, while the S&P 500 /zigman2/quotes/210599714/realtime SPX -0.67% is up 15.6%.

/zigman2/quotes/201724570/composite
US : U.S.: NYSE
$ 170.25
+1.75 +1.04%
Volume: 5.43M
May 10, 2021 2:41p
P/E Ratio
30.07
Dividend Yield
2.49%
Market Cap
$443.73 billion
Rev. per Employee
$613,918
loading...
/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 195.56
+11.85 +6.45%
Volume: 5.84M
May 10, 2021 2:41p
P/E Ratio
1,887
Dividend Yield
N/A
Market Cap
$44.37 billion
Rev. per Employee
$283,276
loading...
/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 40.06
+0.48 +1.21%
Volume: 17.94M
May 10, 2021 2:41p
P/E Ratio
23.46
Dividend Yield
3.89%
Market Cap
$220.78 billion
Rev. per Employee
$533,860
loading...
/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 156.58
-6.57 -4.03%
Volume: 6.84M
May 10, 2021 2:41p
P/E Ratio
125.40
Dividend Yield
N/A
Market Cap
$65.29 billion
Rev. per Employee
$617,996
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,204.25
-28.35 -0.67%
Volume: 1.44B
May 10, 2021 2:41p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.